Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy
- PMID: 12944420
- DOI: 10.1093/hmg/ddg293
Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy
Abstract
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset autosomal dominant muscular dystrophy that results from small expansions of a polyalanine tract in the PABPN1 gene. Intranuclear inclusions are the pathological hallmark of OPMD. The mechanism by which protein aggregation in OPMD might relate to a toxic gain-of-function has so far remained elusive. Whether protein aggregates themselves are pathogenic or are the consequence of an unidentified underlying molecular mechanism is still unclear. Here, we report that protein aggregation in a cell model of OPMD directly impaires the function of the ubiquitin-proteasome pathway (UPP) as well as molecular chaperone functions. The proteasome inhibitor lactacystin causes significant increase of protein aggregation and toxicity. Moreover, overexpression of molecular chaperones (HSP40 and HSP70) suppressed protein aggregation and toxicity. We also provide evidence that mPABPN1-ala17 protein aggregation proportionally correlates with toxicity. Furthermore, we show that co-expression of chaperones in our OPMD cell model increases the solubility of mPABPN1-ala17 and transfected cell survival rate. Our studies suggest that molecular regulators of polyalanine protein solubility and degradation may provide insights into new mechanisms in OPMD pathogenesis. Further analysis of the cellular and molecular mechanisms by which UPP and molecular chaperones influence the degradation of misfolded proteins could provide novel concepts and targets for the treatment and understanding of the pathogenesis of OPMD and neurodegenerative diseases.
Similar articles
-
Induction of HSP70 expression and recruitment of HSC70 and HSP70 in the nucleus reduce aggregation of a polyalanine expansion mutant of PABPN1 in HeLa cells.Hum Mol Genet. 2005 Dec 1;14(23):3673-84. doi: 10.1093/hmg/ddi395. Epub 2005 Oct 20. Hum Mol Genet. 2005. PMID: 16239242
-
Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.Traffic. 2005 Sep;6(9):766-79. doi: 10.1111/j.1600-0854.2005.00315.x. Traffic. 2005. PMID: 16101680
-
Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus.Hum Mol Genet. 2004 Apr 15;13(8):829-38. doi: 10.1093/hmg/ddh101. Epub 2004 Feb 19. Hum Mol Genet. 2004. PMID: 14976164
-
Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.Proc Natl Acad Sci U S A. 2002 Dec 10;99 Suppl 4(Suppl 4):16412-8. doi: 10.1073/pnas.182426899. Epub 2002 Aug 20. Proc Natl Acad Sci U S A. 2002. PMID: 12189209 Free PMC article. Review.
-
Oculopharyngeal muscular dystrophy: potential therapies for an aggregate-associated disorder.Int J Biochem Cell Biol. 2006;38(9):1457-62. doi: 10.1016/j.biocel.2006.01.016. Epub 2006 Feb 28. Int J Biochem Cell Biol. 2006. PMID: 16530457 Review.
Cited by
-
Modulation of Protein Quality Control and Proteasome to Autophagy Switch in Immortalized Myoblasts from Duchenne Muscular Dystrophy Patients.Int J Mol Sci. 2018 Jan 7;19(1):178. doi: 10.3390/ijms19010178. Int J Mol Sci. 2018. PMID: 29316663 Free PMC article.
-
Protein Aggregates and Aggrephagy in Myopathies.Int J Mol Sci. 2023 May 8;24(9):8456. doi: 10.3390/ijms24098456. Int J Mol Sci. 2023. PMID: 37176163 Free PMC article. Review.
-
Depletion of nuclear poly(A) binding protein PABPN1 produces a compensatory response by cytoplasmic PABP4 and PABP5 in cultured human cells.PLoS One. 2012;7(12):e53036. doi: 10.1371/journal.pone.0053036. Epub 2012 Dec 31. PLoS One. 2012. PMID: 23300856 Free PMC article.
-
The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones.Neurobiol Dis. 2007 Feb;25(2):252-65. doi: 10.1016/j.nbd.2006.09.018. Epub 2006 Dec 13. Neurobiol Dis. 2007. PMID: 17174099 Free PMC article.
-
Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.EMBO Mol Med. 2011 Jan;3(1):35-49. doi: 10.1002/emmm.201000109. EMBO Mol Med. 2011. PMID: 21204267 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
